Multivision Translate
A spatial signature made up of 5–40 fluorescent markers is a research result. A signature that works on individual IHC markers and H&E with any standard scanner is a diagnostic test. We are building Translate on our own discoveries first, to turn them into diagnostic tests designed for routine clinical adoption.
Translate will identify the minimal marker set that preserves stratification power, then build a spatial scoring algorithm that makes it deployable as a clinical assay. We will accompany each assay through the regulatory framework, from analytical and clinical validation to regulatory approval in key European and US markets.
- Start Compound spatial biomarker from Decode, validated against outcome.
- Simplify Distill complex signatures into practical marker panels for translational and clinical studies.
- Transfer Transfer the simplified panel into a robust kit‑and‑software assay.
- Protected Secure competitive advantage through proprietary methods and biomarker intellectual property.
Regulatory support throughout